Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 217S · 10 late217 trades$54.77M| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 3 | Raghavan VaidyanathanChief Technology Officer |  XMTRXometry, Inc.Open-market sale · 10b5-1 plan | SELL | $31K 326 sh | Jul 6, 2026 |
| 3 | Raghavan VaidyanathanChief Technology Officer | XMTRXometry, Inc. Open-market sale · 10b5-1 plan | SELL | $9,391 99 sh | Jul 6, 2026 traded Jul 2, 2026 |
| 3 | Raghavan VaidyanathanChief Technology Officer | XMTRXometry, Inc. Open-market sale · 10b5-1 plan | SELL | $49K 529 sh | Jul 6, 2026 traded Jul 2, 2026 |
| 3 | Dutt SubirChief Sales Officer | XMTRXometry, Inc. Open-market sale · 10b5-1 plan | SELL | $13K 137 sh | Jul 6, 2026 traded Jul 2, 2026 |
| 3 | Raghavan VaidyanathanChief Technology Officer | XMTRXometry, Inc. Open-market sale · 10b5-1 plan | SELL | $39K 428 sh | Jul 6, 2026 traded Jul 2, 2026 |
| 3 | Dutt SubirChief Sales Officer | XMTRXometry, Inc. Open-market sale · 10b5-1 plan | SELL | $19K 199 sh | Jul 6, 2026 traded Jul 2, 2026 |
| 3 | Dutt SubirChief Sales Officer | XMTRXometry, Inc. Open-market sale · 10b5-1 plan | SELL | $5,151 53 sh | Jul 6, 2026 traded Jul 2, 2026 |
| 3 | Dutt SubirChief Sales Officer | XMTRXometry, Inc. Open-market sale · 10b5-1 plan | SELL | $9,483 100 sh | Jul 6, 2026 traded Jul 2, 2026 |
| 3 | Dutt SubirChief Sales Officer | XMTRXometry, Inc. Open-market sale · 10b5-1 plan | SELL | $29K 310 sh | Jul 6, 2026 traded Jul 2, 2026 |
| 1 | Bliss KellyPresident, U.S. Group Health |  TDOCTeladoc Health, Inc.Open-market sale · 10b5-1 plan | SELL | $24K 2,500 sh | Jul 6, 2026 traded Jul 6, 2026 |
| 33 | Casey Patrick JohnDirector |  LEGNLegend Biotech CorpOpen-market sale | SELL | $89K 6,000 sh | Jul 2, 2026 traded Jun 30, 2026 |
| 32 | Cochran CarolineDirector, Co-Founder, COO, 10% Owner | OKLOOklo Inc. Open-market sale | SELL | $3.17M 60.0K sh | Jul 2, 2026 traded Jul 1, 2026 |
| 32 | DeWitte JacobDirector, Co-Founder, CEO, 10% Owner | OKLOOklo Inc. Open-market sale | SELL | $3.14M 60.0K sh | Jul 2, 2026 traded Jul 1, 2026 |
| 32 | DeWitte JacobDirector, Co-Founder, CEO, 10% Owner | OKLOOklo Inc. Open-market sale | SELL | $3.17M 60.0K sh | Jul 2, 2026 traded Jul 1, 2026 |
| 32 | Cochran CarolineDirector, Co-Founder, COO, 10% Owner | OKLOOklo Inc. Open-market sale | SELL | $2.15M 40.0K sh | Jul 2, 2026 traded Jul 1, 2026 |
| 32 | DeWitte JacobDirector, Co-Founder, CEO, 10% Owner | OKLOOklo Inc. Open-market sale | SELL | $2.15M 40.0K sh | Jul 2, 2026 traded Jul 1, 2026 |
| 32 | Cochran CarolineDirector, Co-Founder, COO, 10% Owner | OKLOOklo Inc. Open-market sale | SELL | $2.13M 40.0K sh | Jul 2, 2026 traded Jul 1, 2026 |
| 32 | Cochran CarolineDirector, Co-Founder, COO, 10% Owner | OKLOOklo Inc. Open-market sale | SELL | $3.14M 60.0K sh | Jul 2, 2026 traded Jul 1, 2026 |
| 32 | DeWitte JacobDirector, Co-Founder, CEO, 10% Owner | OKLOOklo Inc. Open-market sale | SELL | $2.13M 40.0K sh | Jul 2, 2026 traded Jul 1, 2026 |
| 21 | Narayanan ArunChief Executive Officer |  STEMSTEM, INC.Open-market sale | SELL | $16K 1,996 sh | Jul 2, 2026 traded Jul 2, 2026 |
| 21 | Bernstein HaroldPresident, R&D & CMO | MAZEMaze Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $400K 13.4K sh | Jul 2, 2026 traded Jul 1, 2026 |
| 19 | Rogers Daniel MarkDirector, Chief Executive Officer |  ASANAsana, Inc.Open-market sale · 10b5-1 plan | SELL | $95K 13.8K sh | Jul 2, 2026 traded Jun 30, 2026 |
| 19 | Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder |  HNGEHinge Health, Inc.Open-market sale · 10b5-1 plan | SELL | $4.80M 56.5K sh | Jul 2, 2026 traded Jul 1, 2026 |
| 19 | Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder | HNGEHinge Health, Inc. Open-market sale · 10b5-1 plan | SELL | $1.60M 18.7K sh | Jul 2, 2026 traded Jul 1, 2026 |
| 17 | Lopez Gustavo JavierDirector |  LNDBrasilAgro - Brazilian Agricultural Real Estate CoOpen-market sale | SELL | $6,980 2,000 sh | Jul 2, 2026 traded Jul 1, 2026 |
| 16 | McCulloch KevinSee Remarks |  XERSXeris Biopharma Holdings, Inc.Open-market sale · 10b5-1 plan | SELL | $723K 90.0K sh | Jul 2, 2026 traded Jul 1, 2026 |
| 15 | Bernstein HaroldPresident, R&D & CMO | MAZEMaze Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $36K 1,200 sh | Jul 2, 2026 traded Jul 1, 2026 |
| 13 | Ribeiro RamiroChief Medical Officer |  EYPTEyePoint, Inc.Open-market sale · 10b5-1 plan | SELL | $37K 2,438 sh | Jul 2, 2026 traded Jun 30, 2026 |
| 13 | Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder | HNGEHinge Health, Inc. Open-market sale · 10b5-1 plan | SELL | $64K 741 sh | Jul 2, 2026 traded Jul 1, 2026 |
| 9 | Ribeiro RamiroChief Medical Officer | EYPTEyePoint, Inc. Open-market sale · 10b5-1 plan | SELL | $37K 2,437 sh | Jul 2, 2026 traded Jun 30, 2026 |
| 4 | Katz ZacharyCLO and Head of Global Affairs |  GRNDGrindr Inc.Open-market sale · 10b5-1 plan | SELL | $208K 12.8K sh | Jul 2, 2026 traded Jul 1, 2026 |
| 4 | Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder | HNGEHinge Health, Inc. Open-market sale · 10b5-1 plan | SELL | $290K 3,500 sh | Jul 2, 2026 traded Jul 1, 2026 |
| 4 | Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder | HNGEHinge Health, Inc. Open-market sale · 10b5-1 plan | SELL | $327K 3,900 sh | Jul 2, 2026 traded Jul 1, 2026 |
| 0 | Schubach Sarah ElizabethChief Accounting Officer |  DBXDROPBOX, INC.Open-market sale · 10b5-1 plan | SELL | $35K 1,305 sh | Jul 2, 2026 traded Jun 30, 2026 |
| 47 | Bhalla Narinder PalChief Medical Officer |  LXEOLexeo Therapeutics, Inc.Open-market sale | SELL | $99K 22.3K sh | Jul 1, 2026 traded Jul 1, 2026 |
| 39 | Townsend Richard NolanDirector, Chief Executive Officer | LXEOLexeo Therapeutics, Inc. Open-market sale | SELL | $116K 25.9K sh | Jul 1, 2026 traded Jul 1, 2026 |
| 39 | Bettinger Davo Maria FernandaINVESTOR RELATIONS OFFICER |  VTMXVesta Real Estate Corporation, S.A.B. de C.V.Open-market sale | SELL | $72K 21.2K sh | Jul 1, 2026 traded Jun 29, 2026 |
| 39 | Linz Terrence JamesPresident, Wholesale Brands |  LZBLA-Z-BOY INCOpen-market sale | SELL | $101K 2,500 sh | Jul 1, 2026 traded Jun 30, 2026 |
| 36 | Tamayo Louis EdwardChief Financial Officer | LXEOLexeo Therapeutics, Inc. Open-market sale | SELL | $21K 4,641 sh | Jul 1, 2026 traded Jul 1, 2026 |
| 36 | Zafrani EdenCHRO |  NYAXNayax Ltd.Open-market sale | SELL | $32K 500 sh | Jul 1, 2026 traded Jun 30, 2026 |
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
IBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
BBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K
BCYCBICYCLE THERAPEUTICS PLCOct 2 – Oct 56 insiders$63K